Explore the Global Neuro Immunoassay Market— analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Neuro Immunoassay Market

Key Insight

Reagents and kits will lead neuro immunoassay sales through 2036 with 40.0% share of the product segment in 2026, driven by standardized treatment protocols and established clinical procurement patterns. The market is projected to reach USD 3.2 billion in 2026 and USD 6.38 billion by 2036, creating an incremental opportunity of USD 3.17 billion.

May 07, 2026

Anurag Sharma

306 Pages

Cite this Report

Neuro Immunoassay Market

https://www.futuremarketinsights.com/reports/neuro-immunoassay-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

Abcam plc
Beckman Coulter Diagnostics
Bio-Rad Laboratories
Fujirebio
Meso Scale Diagnostics
PerkinElmer
Quanterix Corporation
Hoffmann-La Roche
Siemens
Thermo Fisher Scientific Inc.

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Neuro Immunoassay Market

Key Players

Similar Industry Reports